Zynerba Pharmaceuticals News - ZYNE

Company Name	Stock Ticker Symbol	Market	Type
Zynerba Pharmaceuticals Inc	ZYNE	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	1.30	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
			1.30	1.30

more quote information »

Recent News

Date	Time	Source	Heading
2/08/2024	19:22	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
10/19/2023	16:48	EDGAR2	Form 15-12G - Securities registration termination [Section..
10/12/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
10/11/2023	10:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/11/2023	10:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/11/2023	10:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/11/2023	10:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/11/2023	09:27	EDGAR2	Form POS AM - Post-Effective amendments for registration..
10/11/2023	09:27	EDGAR2	Form S-8 POS - Securities to be offered to employees in..
10/11/2023	08:56	EDGAR2	Form SC 14D9/A - Solicitation, recommendation statements:..
10/11/2023	08:31	EDGAR2	Form SC TO-T/A - Tender offer statement by Third Party:..
10/11/2023	08:17	EDGAR2	Form 8-K - Current report
10/11/2023	08:00	PRNUS	HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA..
10/04/2023	17:29	EDGAR2	Form SC 14D9/A - Solicitation, recommendation statements:..
10/04/2023	16:05	GLOBE	Important Information for Zynerba Pharmaceuticals..
9/29/2023	09:00	GLOBE	Zynerba Pharmaceuticals Stockholders Reminded to Tender..
9/27/2023	08:25	EDGAR2	Form SC 14D9/A - Solicitation, recommendation statements:..
9/27/2023	08:12	EDGAR2	Form SC TO-T/A - Tender offer statement by Third Party:..
9/27/2023	08:00	PRNUS	HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO..
9/15/2023	08:00	EDGAR2	Form SC 14D9/A - Solicitation, recommendation statements:..
9/14/2023	16:59	EDGAR2	Form SC TO-T/A - Tender offer statement by Third Party:..
9/14/2023	16:16	EDGAR2	Form SC 14D9/A - Solicitation, recommendation statements:..
9/14/2023	16:15	GLOBE	Zynerba Pharmaceuticals Presents Positive Data from Phase 2..
9/14/2023	16:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/14/2023	16:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/05/2023	16:39	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
8/29/2023	16:05	EDGAR2	Form 8-K - Current report
8/28/2023	09:05	EDGAR2	Form SC 14D9 - Solicitation, recommendation statements
8/28/2023	08:23	EDGAR2	Form SC TO-T - Tender offer statement by Third Party
8/24/2023	17:23	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
8/15/2023	16:05	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
8/14/2023	17:29	EDGAR2	Form SC TO-C - Written communication relating to an issuer..
8/14/2023	17:26	EDGAR2	Form SC TO-C - Written communication relating to an issuer..
8/14/2023	17:20	EDGAR2	Form SC14D9C - Written communication relating to third party..
8/14/2023	07:45	EDGAR2	Form SC14D9C - Written communication relating to third party..
8/14/2023	07:42	EDGAR2	Form 8-K - Current report
8/14/2023	07:36	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	07:30	PRNUS	HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.
8/08/2023	16:13	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
8/08/2023	16:05	GLOBE	Zynerba Pharmaceuticals Announces New Date for Reconvened..
7/25/2023	17:24	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
7/25/2023	17:18	GLOBE	Zynerba Pharmaceuticals Announces New Date for Reconvened..
6/28/2023	16:21	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
6/28/2023	16:05	GLOBE	Zynerba Pharmaceuticals Announces Further Adjournment of..
6/20/2023	07:00	GLOBE	Zynerba Pharmaceuticals to Present at the H.C. Wainwright..
6/13/2023	16:05	GLOBE	Zynerba Pharmaceuticals Announces Partial Adjournment of..
5/23/2023	07:00	GLOBE	Zynerba Pharmaceuticals Announces Podium and Poster..
5/15/2023	07:00	GLOBE	Zynerba Pharmaceuticals Reports First Quarter 2023 Financial..